IGG DONOR-SPECIFIC ANTI-HLA ANTIBODY SUBCLASSES AFTER SUCCESSFUL DESENSITIZATION TREATMENT IN KIDNEY TRANSPLANTATION

被引：0
|
作者：
Park, Younhee [1 ]
Kim, Borahm [1 ]
Kim, Hyon-Suk [1 ]
机构：
[1] Yonsei Univ, Severance Hosp, Dept Lab Med, Coll Med, Seoul, South Korea
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
PO122
引用
收藏
页码：345 / 345
页数：1
相关论文
共 50 条
  • [31] INPACT OF PREFORMED DSA C1Q-BINDING DONOR-SPECIFIC ANTI-HLA ANTIBODY IN KIDNEY TRANSPLANTATION
    Kurihara, Kei
    Kaku, Keizo
    Noguchi, Hiroshi
    Okabe, Yasuhiro
    Nakamura, Masafumi
    TRANSPLANT INTERNATIONAL, 2017, 30 : 471 - 471
  • [32] The Prediction of Molecular ABMR by Anti-HLA Donor-Specific Antibody Properties
    Eskandary, F.
    Reeve, J.
    Yoo, D.
    Regele, H.
    Hidalgo, L.
    Bohmig, G.
    Halloran, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 706 - 707
  • [33] Mycophenolate mofetil (MMF) effect on anti-HLA donor-specific antibody (DSA) after pediatric living donor transplantation.
    Ueno, Takehisa
    Takase, Koki
    Uga, Naoko
    Deguchi, Koichi
    Nomura, Motonari
    Watanabe, Miho
    Kamiyama, Masafumi
    Kimura, Takeshi
    Okuyama, Hiroomi
    TRANSPLANTATION, 2024, 108 (9S)
  • [34] Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation
    Salvade, Igor
    Aubert, Vincent
    Venetz, Jean-Pierre
    Golshayan, Dela
    Saouli, Anne-Catherine
    Matter, Maurice
    Rotman, Samuel
    Pantaleo, Giuseppe
    Pascual, Manuel
    HUMAN IMMUNOLOGY, 2016, 77 (06) : 483 - 489
  • [35] REASSESSMENT OF THE CLINICAL IMPACT OF PREFORMED DONOR-SPECIFIC ANTI-HLA CW ANTIBODIES IN KIDNEY TRANSPLANTATION
    Visentin, J.
    Bachelet, T.
    Aubert, O.
    Del Bello, A.
    Martinez, C.
    Jambon, F.
    Guidicelli, G.
    Ralazamahaleo, M.
    Bouthemy, C.
    Cargou, M.
    Congy-Jolivet, N.
    Nong, T.
    Lee, J. H.
    Sberro-Soussan, R.
    Couzi, L.
    Kamar, N.
    Legendre, C.
    Merville, P.
    Taupin, J. L.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 6 - 6
  • [36] Acceptable Donor-Specific Antibody Levels Before and After Desensitization Therapy in Living Donor Kidney Transplantation
    In, Ji Won
    Nam, Minjeong
    Rho, Eun Youn
    Shin, Sue
    Hong, Yun Ji
    Park, Kyoung Un
    Song, Eun Young
    CLINICAL LABORATORY, 2020, 66 (1-2) : 155 - 160
  • [37] Desensitization for renal transplantation: depletion of donor-specific anti-HLA antibodies, preservation of memory antibodies, and clinical risks
    Rogers, Natasha M.
    Eng, Hooi S.
    Yu, Raymond
    Kireta, Svjetlana
    Tsiopelas, Eleni
    Bennett, Greg D.
    Brook, Nicholas R.
    Gillis, David
    Russ, Graeme R.
    Coates, P. Toby
    TRANSPLANT INTERNATIONAL, 2011, 24 (01) : 21 - 29
  • [38] SUCCESSFUL KIDNEY TRANSPLANTATION IN A HIGHLY SENSITISED RECIPIENT: ABILITY OF COMBINED LIVER TRANSPLANT TO DEPLETE DONOR-SPECIFIC ANTI-HLA ANTIBODIES
    Stephenson, M.
    Chen, J.
    Russell, C.
    Bennett, G.
    Coates, P.
    NEPHROLOGY, 2010, 15 : 41 - 41
  • [39] Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in children
    Petit, L. -M.
    Rabant, M.
    Canioni, D.
    Suberbielle-Boissel, C.
    Goulet, O.
    Chardot, C.
    Lacaille, F.
    PEDIATRIC TRANSPLANTATION, 2017, 21 (02)
  • [40] IMPACT OF EARLY BLOOD TRANSFUSION AFTER KIDNEY TRANSPLANTATION ON THE INCIDENCE OF DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES
    Saito, Mitsuru
    Satoh, Shigeru
    Saito, Takuro
    Yamamoto, Ryohei
    Nara, Taketoshi
    Chiba, Syuji
    Kanda, Sohei
    Numakura, Kazuyuki
    Narita, Shintaro
    Inoue, Takamitsu
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1043 - E1043
12345